title: Argatroban therapy using enzymatic anti-factor IIa monitoring.
authors.forename: Michele F
authors.initials: MF
authors.lastname: Shepherd
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Jacobsen
authors.forename: Terry K
authors.initials: TK
authors.lastname: Rosborough
mesh_terms: D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D016903:Drug Monitoring; D006801:Humans; D010875:Pipecolic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D011516:Prothrombin / Q000032:analysis*; D013449:Sulfonamides
chemical_list: D000991:Antithrombins; D010875:Pipecolic Acids; D013449:Sulfonamides; D011516:Prothrombin; C025337:Factor IIa; D001120:Arginine; C031942:argatroban